Data also suggested that the neural stem cell–like GBM stem cell (GSC), also known as brain tumor-initiating cell (BTIC), fraction that is associated with therapeutic resistance may be enriched with knockout of Il1a and Il1b compared with loss of Il1b alone (8). Here, IL1B is linked to glioblastoma.